What We Do:

The mission of the NIDA Brain Development Research Consortium is to foster translational science on brain development, cognition, behavior and functioning to advance the understanding of drug abuse and addiction, prevention, treatment and recovery within the scientific mission areas of NIDA.

The Brain Development Research Consortium includes a multidisciplinary group of NIDA staff representing diverse programs and offices working to enhance basic and clinical research on drug abuse by examining neurodevelopment, addiction and the complex interplay of contextual, behavioral, and genetic factors.

Pediatric Imaging, Neurocognition, and Genetics (PING) is a large MRI and genetics data resource shared openly with the scientific community that includes information about the developing mental and emotional functions of the children between the ages of 3 and 20 years so that links between genetic variation and developing patterns of brain connectivity can be examined.

Pediatric HIV/AIDS Cohort Study (PHACS) is a longitudinal cohort study investigating the long-term effects of HIV infection and ARV (antiretroviral) medications in children and young adults who were born with HIV or born exposed to HIV developed by NICHD and co-funded by NIDA, NIAAA, NIAID, NIDCD, NHBLI, NIMH, NIDS, and OAR.

PhenX (consensus measures for Phenotypes and eXposures) Toolkit is a catalog of recommended, standard measures of phenotypes and environmental exposures for use in biomedical research. PhenX measures that are relevant to development, substance abuse and addiction (SAA) research are included in several research domains.

NIH Toolbox is a multidimensional set of brief measures assessing cognitive, emotional, motor and sensory function from ages 3 to 85, meeting the need for a standard set of measures that can be used as a “common currency” across diverse study designs and settings.